Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer.
about
Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Ceritinib compassionate use fo ...... ed non-small-cell lung cancer.
@en
Ceritinib compassionate use fo ...... ed non-small-cell lung cancer.
@nl
type
label
Ceritinib compassionate use fo ...... ed non-small-cell lung cancer.
@en
Ceritinib compassionate use fo ...... ed non-small-cell lung cancer.
@nl
prefLabel
Ceritinib compassionate use fo ...... ed non-small-cell lung cancer.
@en
Ceritinib compassionate use fo ...... ed non-small-cell lung cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Ceritinib compassionate use fo ...... ed non-small-cell lung cancer.
@en
P2093
Alberto Rebonato
Alessandro Tuzi
Annamaria Carta
Domenico Galetta
Enrica Capelletto
Fabiana L Cecere
Giulio Metro
Giuseppe Tonini
Hector Soto Parra
Laura Bonanno
P2860
P304
P356
10.2217/FON-2017-0441
P407
P50
P577
2017-11-14T00:00:00Z